Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Luis Sanchez, MD
Barnes Jewish Hospital, Washington Univ
Principal Investigator - Wilson Szeto, MD
Penn Presbyterian Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Southern California
Los Angeles, California, United States
- University of Florida
Gainesville, Florida, United States
- Emory University
Atlanta, Georgia, United States
- University of Maryland
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Barnes Jewish Hospital at Washington University
St Louis, Missouri, United States
- Columbia University Medical Center
New York, New York, United States
- Duke University
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Hospital of the University of Pennsylvania/penn Presbyterian
Philadelphia, Pennsylvania, United States
- Baylor College of Medicine
Houston, Texas, United States
- Baylor Scott and White Research Institute
Plano, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Dec 2017
- Primary completion
- 18 Sept 2023
- Completion
- 31 Aug 2028
- Last update posted
- 31 May 2025
- Registered enrollment
- 30
- Registry id
- NCT03214601
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.